JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Paediatrics Section DOI : 10.7860/JCDR/2016/19205.8775
Year : 2016 | Month : Nov | Volume : 10 | Issue : 11 Full Version Page : SC01 - SC04

Congenital Cystic Adenomatoid Malformation: A Tertiary Care Hospital Experience

Asmita Anilkumar Mehta1, Naveen Viswanathan2, Anil Kumar Vasudevan3, Roopa Paulose4, Mohan Abraham5

1 Clinical Professor, Department of Pulmonary Medicine, Amrita Institute of Medical Sciences, Ponekara, Kochi, Kerala, India.
2 Clinical Professor, Department of Paediatric Surgery, Amrita Institute of Medical Sciences, Ponekara, Kochi, Kerala, India.
3 Clinical Professor, Department of Microbiology, Amrita Institute of Medical Sciences, Ponekara, Kochi, Kerala, India.
4 Associate Professor, Department of Pathology, Amrita Institute of Medical Sciences, Ponekara, Kochi, Kerala, India.
5 Professor and Head, Department of Paediatric Surgery, Amrita Institute of Medical Sciences, Ponekara, Kochi, Kerala, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Asmita Anilkumar Mehta, Clinical Professor, Department of Pulmonary Medicine, Amrita Institute of Medical Sciences, Ponekara, Kochi-682041, Kerala, India.
E-mail: asmitamehta790@gmail.com
Abstract

Introduction

Congenital Cystic Adenomatoid Malformation (CCAM) is an uncommon developmental deformity affecting the terminal respiratory structures. It is characterized by broncho pulmonary foregut malformations. The reason behind it is an arrest in lung development between 4th and 7th week of fetal life.

Aim

The present study was conducted to assess the clinical and radiological profile and also to study the role of surgical intervention in patients with CCAM.

Materials and Methods

All patients with clinical suspicion or provisional diagnosis of CCAM were included in the study. A clinical questionnaire was prepared to collect data. Computed Tomography (CT) chest with High Resolution Computed Tomography (HRCT) was done for all the patients. Patients were assessed by paediatric surgeon and eligible patients were operated. The procedure conducted was usually open thoracotomy under general anaesthesia. The affected lobes were removed and specimens were sent for histopathological analysis. All included patients were followed up prospectively to find out about their current level of health. Via telephonic interview they were asked about their overall growth, quality of life, activity, rate of respiratory infections and requirement of hospital admission.

Results

Total 15 patients with diagnosis of CCAM were included in the study. Of them, 8 (53.3%) were male. The commonest presentation was cough 13(86%), breathing difficulty 11(73%), fever 9(60%), recurrent pneumonia 4(26%), hypoxia requiring oxygen supplementation 6(40%), others 2(12%). Thirteen patients required surgical intervention and underwent lobectomy. There were 2 cases of type I, one each of type II and III, 3 case of type IV while 5 were intermediate type. There was no procedure related mortality. The median duration of hospital stay and all were successfully discharged with median duration of stay 11±16 days.

Conclusion

The study concludes that if recognized early, surgical removal of affected lung prevents the complications like recurrent pulmonary infections. The surgery is well tolerated without any post-operative mortality or morbidity.

Keywords

Introduction

Congenital Cystic Adenomatoid Malformation (CCAM) of the lung is a rare developmental abnormality with incidence rate of 1 in 11000 to 1 in 35000 live birth [1,2]. It happens due to bronchopulmonary foregut malformations that are probably caused by an arrest in lung development between 4th and 7th week of fetal life [13]. It does not have any genetic predisposition, gender predilection [4]. It is not affected by maternal factors such as race, age or environmental exposures [4].

There are reports showing that CCAM can transform into malignancies, such as bronchioloalveolar carcinoma [5], adenocarcinoma in aged [6], and pleuropulmonary blastoma [7]. Surgical removal of the affected lobe of the lung is the best treatment for CCAM. It also prevents future complications like recurrent infections and potential risk of malignant transformation [810]. CCAM is an uncommon congenital disease with limited data available in the form of case reports. It is important to identify such cases early so that early rectifying procedure can be attempted. Being a tertiary care hospital, our’s is a referral centre for treating such cases. This study was undertaken to present the experience of a tertiary care hospital in treating CCAM. The primary objective of the present study was to assess the clinical and radiological profile of CCAM in a tertiary care hospital. Secondary objectives were to study management and outcome of surgical intervention in case of CCAM.

Materials and Methods

The study was conducted at tertiary care academic institute. It was retrospective study conducted at tertiary care teaching institute. Patients’ data were collected from electronic medical records. All patients with either prenatal diagnosis of CCAM on antenatal ultrasound or patients having High Resolution Computed Tomography (HRCT) features suggestive of CCAM between 2006 to 2013 were included in the study. Other mimicking conditions like congenital lobar emphysema, bronchogenic cyst, bronchopulmonary sequestration, prior infection with pneumatocele and congenital diaphragmatic hernia were excluded.

A clinical questionnaire was prepared to retrieve data. It included age, gender, type and site of CCAM, symptoms at time of presentation, surgery conducted, duration of hospital stay and post-operative complication. Breathing difficulty or sucking difficulty was taken as equal. Acute respiratory distress was defined as hypoxic child with SPO2 <90% requiring supplemental oxygen. All patients had chest radiograph as initial investigation if there was high clinical radiological suspicion for CCAM, patients were subjected to CT chest with HRCT. Paediatric surgeon assessed the patient for feasibility of surgery and eligible patients were operated. Standard procedure was followed for surgery and patients were subjected to open thoracotomy under general anaesthesia. The affected lobes were removed and specimens were sent for histopathological analysis.

All included patients were followed up prospectively to find out about their current level of health. Via telephonic interview they were asked about their overall growth, quality of life, activity, rate of respiratory infections and requirement of hospital admission.

Statistical Analysis

Results are expressed as Mean±SD. The statistical analyses were done by SPSS version 11(SPSS inc. Chicago). Descriptive frequencies were expressed by mean±standard deviation.

Results

Total 15 patients with diagnosis of CCAM were included in the study. There were 8 (53.3%) male while the remaining 7 were female. Baseline characteristics of the study cohort are shown in [Table/Fig-1]. Five cases were detected on antenatal screening ultrasound while the rest were post-natal diagnosis. Three patients were also found to have other co-existing congenital abnormality: 2 with atrial septal defect and one with patent ductus arteriosus.

Baseline demographics of study population.

CharacterValue(n=15)
Age, year, median(range)0.3 (0.10-24)
Gender: •  Male •  Female8(53.3%)7(46.7%)
Symptoms at time of presentation •  Cough •  Breathing difficulty •  Fever •  ARDS •  Failure to thrive •  Recurrent pneumonia13(86.7%)11(73.3%)9(60%)6(40%)4(26.7%)4(26.7%)
Antenatal detection5(33.33%)
Other congenital abnormalities •  Atrial septal defect •  Patent ductus arteriosus2(13.3%)1(6.66%)

The most common presentation was cough 13 (86%), breathing difficulty 11 (73%), fever 9 (60%), recurrent pneumonia 4 (26%), acute respiratory distress (hypoxia requiring supplemental oxygen) 6 (40%), one patient with abdominal distension and one presented with vomiting and seizure (others) 2 (12%).

There were 8 case of right sided (4 Right Upper Lobe (RUL), 3 Right Lower Lobe (RLL), 1 Right Middle Lobe (RML), 6 cases of left sided CCAM (2 Left Upper Lobe (LUL), 4 Left Lower Lobe (LLL)), and 1 case of bilateral CCAM [Table/Fig-2,3 and 4]. Various radiology images of study patients are depicted in [Table/Fig-5].

Graph showing side of affected lung due to CCAM.

Graph showing lobar distribution on left side.

Graph showing lobar distribution on right side.

showing HRCT images showing various types of CCAM.

Thirteen patients were subjected to surgical management in the form of lobectomy. Gross appearance of CCAM is shown in [Table/Fig-6]. All were confirmed to have CCAM on histopathology [Table/Fig-7]. There were 2 cases of type I, one each of type II and III, 3 case of type 4 while 5 were intermediate type [Table/Fig-8] and one was reported as CCAM with haemorrhage. Patients were followed up in post-surgery period for post-operative complications. We did not observe any post-operative complications. There was no procedure related mortality and all were successfully discharged with median duration of stay 11±16 days. All patients had good post-operative recovery. One patient had bilateral disease and was not a candidate for surgery, so was managed conservatively and one patient was managed with medical management alone [Table/Fig-9].

Showing CCAM in post lobectomy gross specimen.

Histopathology picture showing congenital cystic adenomatoid malformation- Type 3. Bronchiolar structures are separated by densely packed irregular spaces lined by cuboidal epithelial cells, resembling fetal lung. {haemotoxylin and eosin (H&E) x100}.

Graph showing histopathology types of CCAM.

Primary and secondary end points.

End pointValue n(%)
Primary end points •  Duration of hospital stay, days (median) •  Complications following the procedure11 (2 - 51)Nil
Secondary end pointsFollow-up •  Follow-up •  Procedure not done •  Lost for follow-up •  Overall growth     Normal     Average     Poor •  Respiratory Infections     < 1 in month     > 1 in month •  Hospital admission     < 3 in a year     > 3 in a year •  Activity capacity     Normal     Average •  Poor10 (66.6%)2(13.3%)3 (20%)7(70%)2(20%)1(10%)7(70%)3(30%)9(90%)1(10%)6(60%)4(40%)0

Included patients’ parents were contacted via telephone and enquired about child’s growth, activity score, and infection rate as well as need of hospitalization in post-surgical period. We could contact and arrange for follow-up in 10 patients. The information of follow-up is shown in [Table/Fig-9].

Discussion

In this series 15 cases of CCAM, a rare developmental, non-hereditary, hamartomatous abnormality of the lower respiratory tract were studied. Most of the population 12 (80%) were below 2 years of age. Male: Female were 1.14:1 and as described in literature we also did not find any significant gender predominance. Now-a-days, the majority of cases are identified by prenatal ultrasound examinations [9]. In our series there were 5 cases in which diagnosis was made on antenatal ultrasound. The median age of presentation in the study was 0.3±6 months.

As per literature, patients may present with symptoms, including cough, dyspnea, haemoptysis and respiratory distress, or remain asymptomatic [4]. The typical manifestations include progressive respiratory distress in the newborn and recurrent pulmonary infections in older children. In present series, cough and dyspnea were the commonest symptoms at time of presentation. However, there were six patients who presented with acute respiratory distress.

Recurrent or non-responding pulmonary infection is the most frequent complication of CCAM followed by haemopneumothorax, haemoptysis, and chronic cough [1,2].

Surgical resection of the affected part of the lung is the treatment of choice and this prevents recurrent infections and malignant transformation. Present study showed that lobectomy was a procedure with few complications [8]. It required a short hospital stay with mean duration of hospital stay of 11 days.

Its occurrence is sporadic and is not related to genetic predisposition, gender predilection, or maternal factors such as race, age, or environmental exposures. Stocker et al., suggested a new name, congenital pulmonary airway malformation and classified CCAM into five types based on the site of the defect in the tracheobronchial tree [2]. CCAM type 0 originates from tracheal or bronchial tissue, type 1 originates from distal bronchi or proximal bronchioles, types 2 and 3 have an acinar origin; type 4 have an acinar-alveolar origin.

Type 0 is the very uncommon, comprising 1 to 3% of cases. It originates from tracheal or bronchial tissue [11]. We did not have any case having type 0 CCAM.

Type 1 is the most common form of CCAM, comprising 60 to 70% [12]. In present study 15.4% of cases were of type I CCAM. The clinical presentation of type 1 of CCAM depends primarily on the size of the cysts. Larger cysts compressing the normal adjacent lung may be detected on prenatal ultrasound and can cause respiratory distress in the neonate, mediastinal shift to the contra-lateral side and flattening of the ipsilateral diaphragm. All two cases in our series had cough and breathing difficulty.

Type II lesions comprise 15 to 20% of CCAMs as per literature. They consist of multiple cysts 0.5 to 2 cm in diameter; resemble dilated terminal bronchioles lined with ciliated cuboidal or columnar epithelium. In present series there were 7.8% cases of CCAM type II. Extralobar pulmonary sequestrations may have a similar appearance, but unlike type II CCAM, these have a systemic blood supply. Type II CCAM is associated with other congenital abnormalities like esophageal atresia, tracheoesophageal fistula [13], bilateral renal agenesis or dysgenesis [14], intestinal atresia, other pulmonary malformations, and diaphragmatic, cardiac, central nervous system, and bony anomalies in about 60% of cases [2,1113]. In our series the patient having CCAM type II also had Arterial Septal Defect (ASD). This association with other congenital malformations suggests that insults resulting in type 2 CCAMs occur during the third week of gestation. In many cases, the associated anomalies are the presenting feature, and the CCAM is detected as a secondary finding.

Incidence of Type III CCAM is 5 to 10%. In our study it was 7.8% which correlates with reported incidence. They have an acinar origin and are often very large involving an entire lobe or several lobes. Affected infants present in utero or at birth, with severe respiratory distress or death in the neonatal period [12]. Our patient reported at age of 4 months.

Type IV lesions comprise 10 to 15% of CCAMs [10]. In present series we found 23% cases of CCAM. Type IV CCAMs may present at birth or in childhood, often with tension pneumothorax or infection, but they may also be identified as incidental findings in asymptomatic patients. The time of presentation was 0.4 months – 3 year. The presenting symptoms were cough, fever, dyspnea, and one presented with recurrent lung infections. As type IV CCAM has been associated with the development of malignancies, such as bronchioloalveolar carcinoma, adenocarcinoma in aged, and pleuropulmonary blastoma, we feel surgery was treatment of choice in majority of our patients.

There were 5 cases of intermediate type. We did not find any significant post-operative complications and all patients had good post-operative recovery.

In present series, maximum number of patients had lobectomy. As per literature, after lobectomy usually the remaining lung expands well and grows so the pulmonary function test returns to normal [12,13].

In present study, follow-up was done of 10 cases out of 13 operated cases and their overall growth was assessed. Total 70% patients had normal overall growth and less than 1 episode of respiratory tract infection per month. Ninety percentage patients required less than 3 times hospital admission per year. However, we were not able to do pulmonary function test for any of the patients considering their young age.

English literature has multiple single case reports of CCAM with or without infections from India. One previous study from India included all kind of pulmonary malformation and was not specific for CCAM [14]. On literature search, one similar study from Argentina was found comprising 172 cases [15]. Comparison of our study with quoted study is shown in [Table/Fig-10].

Comparison of present study with previously published largest series.

VariablePresentstudy*(n=15)Giubergia Vet al., 2012Argentina(n=172) [15]
Age at presentation0.3±6 months0.1-48 months
Male53.350.4
Prenatal diagnosis33.3314.53%
Clinical presentation •  Recurrent infection •  Respiratory distress •  Pleural effusion •  Asymptomatic26.740013.340%49%8.210
Surgery •  Lobectomy/ Bilobectomy •  Pneumonectomy86.66098.81.2
Other congenital anomalies Cardiac2010.5
Lobar distribution of CCAM •  RUL •  RML •  RLL •  Lingular lobe •  Left LL •  Bilateral26.76.62013.326.76.6622%12%38%4%24%0.58
Type of CCAM •  0 •  1 •  II •  III •  IV •  Intermediate015.47.87.82338.40.5870240.5845.23

Limitation

Present study was retrospective in nature. The study numbers was also very small due to rarity of the disease. It was done at tertiary care hospital and so may not be applicable to general population as such. The study can be used as pilot study for future larger multi center trial.

Conclusion

CCAM is associated with significant morbidity if kept unattended. Removal of affected lobe is treatment of choice for CCAM. We found lobectomy a safe procedure with no significant post-operative complications and good post-operative recovery. Almost 70% patients who underwent surgery had normal growth, physical activity and lesser respiratory infections at 3 years interval.

References

[1]Gornall AS, Budd JL, Draper ES, Konje JC, Kurinczuk JJ, Congenital cystic adenomatoid malformation: accuracy of prenatal diagnosis, prevalence and outcome in a general population Prenat Diagn 2003 23:997-1002.  [Google Scholar]

[2]Stocker JT, The respiratory tract. In: Stocker JT, Dehner LP, eds Pediatric pathology 2001 Philadelphia, PALippincott Williams & Wilkins:445-517.  [Google Scholar]

[3]Benouaich V, Marcheix B, Begueret H, Brouchet L, Velly JF, Jougon J, Malignancy of congenital cystic adenomatoid malformation of lung in aged Asian Cardiovasc Thorac Ann 2009 17:634-36.  [Google Scholar]

[4]Nur S, Badr R, Sandoval C, Brudniki A, Yeh A, Syndromic presentation of a pleuropulmonary blastoma associated with congenital cystic adenomatoid malformation: a case report J Pediatr Surg 2007 42:1772-77.  [Google Scholar]

[5]Langston C, New concepts in the pathology of congenital lung malformations Semin Pediatr Surg 2003 12:17-37.  [Google Scholar]

[6]Lantuejoul S, Nicholson AG, Sartori G, Piolat C, Danel C, Brabencova E, Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors Am J Surg Pathol 2007 31:961-69.  [Google Scholar]

[7]Hill DA, Jarzembowski JA, Priest JR, Williams G, Schoettler P, Dehner LP, Type I pleuropulmonary blastoma; pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry Am J Surg Pathol 2008 32:282-95.  [Google Scholar]

[8]Stanton M, Njere I, Ade-Ajayi N, Patel S, Davenport M, Systematic review and meta-analysis of the postnatal management of congenital cystic lung lesions J Pediatr Surg 2009 44:1027-33.  [Google Scholar]

[9]Tsai AY, Liechty KW, Hedrick HL, Bebbington M, Wilson RD, Johnson MP, Outcomes after postnatal resection of prenatally diagnosed asymptomatic cystic lung lesions J Pediatr Surg 2008 43:513-17.  [Google Scholar]

[10]van Koningsbruggen S, Ahrens F, Brockmann M, Michalk D, Rietschel E, Congenital cystic adenomatoid malformation type 4 Pediatr Pulmonol 2001 32:471  [Google Scholar]

[11]Priest JR, Williams GM, Hill DA, Dehner LP, Jaffé A, Pulmonary cysts in early childhood and the risk of malignancy Pediatr Pulmonol 2009 44:14  [Google Scholar]

[12]Laberge JM, Puligandla P, Flageole H, Asymptomatic congenital lung malformations Semin Pediatr Surg 2005 14:16-33.  [Google Scholar]

[13]Laberge JM, Flageole H, Pugash D, Khalife S, Blair G, Filiatrault D, Outcome of the prenatally diagnosed congenital cystic adenomatoid lung malformation: a Canadian experience Fetal Diagn Ther 2001 16:178-86.  [Google Scholar]

[14]Kumar B, Agrawal LD, Sharma SB, Congenital bronchopulmonary malformations: A single-center experience and a review of literature Ann Thorac Med 2008 3:135-39.  [Google Scholar]

[15]Giubergia V, Barrenechea M, Siminovich M, Pena HG, Murtagh P, Congenital cystic adenomatoid malformation: clinical features, pathological concepts and management in 172 cases J Pediatr (Rio J) 2012 88(2):143-48.  [Google Scholar]